Why should you partner with EmergingMed?
EmergingMed's 14 year operating experience has confirmed feedback first gathered by our staff in 1999 during a series of interviews with patients and families, study teams, advocates, and regulators. We incorporated this feedback into the technology, data and workflows embedded in the CTNS. The highlights include:
Our Primary Solution
EmergingMed's Clinical Trial Navigation Service (CTNS) is a turn-key, hosted solution that enables advocacy groups, trial sponsors, trial sites and research consortia to offer accurate, unbiased clinical trial education, matching and referral services to their constituents.
A privately branded CTNS allows our clients to feature their subset of trials from the national database in the first-pass match results, such as trials being offered at one location, trials designed for patients with a single tumor type, or trials sponsored by their organization.
When EmergingMed is asked to feature a sub-set of trials for a client's privately branded CTNS, we include easy access to a patient's matches from the national database in second-pass match results. The result is a network effect not seen by solutions with one-and-done, single study support. Our partner-specific CTNSs optimize the partner's referral and enrollment rates while also optimizing a patient's access to clinical trial options. Our partners' trials benefit from concierge support regardless of the channel or partner through which the patient or physician identified the trial match.